JP2024524526A5 - - Google Patents
Info
- Publication number
- JP2024524526A5 JP2024524526A5 JP2024500087A JP2024500087A JP2024524526A5 JP 2024524526 A5 JP2024524526 A5 JP 2024524526A5 JP 2024500087 A JP2024500087 A JP 2024500087A JP 2024500087 A JP2024500087 A JP 2024500087A JP 2024524526 A5 JP2024524526 A5 JP 2024524526A5
- Authority
- JP
- Japan
- Prior art keywords
- cytosine
- st6galnac5
- seq
- position corresponding
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163217937P | 2021-07-02 | 2021-07-02 | |
| US63/217,937 | 2021-07-02 | ||
| PCT/US2022/035741 WO2023278713A1 (en) | 2021-07-02 | 2022-06-30 | Treatment of cognitive impairment with alpha-n-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (st6galnac5) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524526A JP2024524526A (ja) | 2024-07-05 |
| JP2024524526A5 true JP2024524526A5 (https=) | 2025-07-03 |
Family
ID=82742788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500087A Pending JP2024524526A (ja) | 2021-07-02 | 2022-06-30 | α－Ｎ－アセチルガラクトサミニドα－２，６－シアリルトランスフェラーゼ５（ＳＴ６ＧＡＬＮＡＣ５）阻害剤による認知障害の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230034093A1 (https=) |
| EP (1) | EP4363582A1 (https=) |
| JP (1) | JP2024524526A (https=) |
| KR (1) | KR20240042611A (https=) |
| CN (1) | CN117836411A (https=) |
| AU (1) | AU2022300980A1 (https=) |
| CA (1) | CA3223334A1 (https=) |
| IL (1) | IL309386A (https=) |
| WO (1) | WO2023278713A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100029748A1 (en) * | 2008-08-04 | 2010-02-04 | Sloan-Kettering Institute For Cancer Research | Metastasis Promoting Genes and Proteins |
-
2022
- 2022-06-30 WO PCT/US2022/035741 patent/WO2023278713A1/en not_active Ceased
- 2022-06-30 US US17/854,759 patent/US20230034093A1/en active Pending
- 2022-06-30 IL IL309386A patent/IL309386A/en unknown
- 2022-06-30 EP EP22748151.2A patent/EP4363582A1/en active Pending
- 2022-06-30 CN CN202280057214.5A patent/CN117836411A/zh active Pending
- 2022-06-30 AU AU2022300980A patent/AU2022300980A1/en active Pending
- 2022-06-30 JP JP2024500087A patent/JP2024524526A/ja active Pending
- 2022-06-30 KR KR1020247003955A patent/KR20240042611A/ko active Pending
- 2022-06-30 CA CA3223334A patent/CA3223334A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| George et al. | Adenosine deaminases acting on RNA, RNA editing, and interferon action | |
| WO2018175502A2 (en) | Treating cancer with cas endonuclease complexes | |
| Toonen et al. | Intracerebroventricular administration of a 2′-O-methyl phosphorothioate antisense oligonucleotide results in activation of the innate immune system in mouse brain | |
| JP7553036B2 (ja) | ｓｎｏＲＮＡの発現抑制剤を有効成分とするがん増殖抑制剤 | |
| JP2022523301A5 (https=) | ||
| WO2021107005A1 (ja) | サイトメガロウイルス関連疾患の予防又は治療用の剤 | |
| US20250332231A1 (en) | Treating cancer with cas endonuclease complexes | |
| Iwaki et al. | Accumulation of αB-crystallin in brains of patients with Alexander's disease is not due to an abnormality of the 5′-flanking and coding sequence of the genomic DNA | |
| EP2484780A1 (en) | Methods and materials for determining pain sensibility and predicting and treating related disorders | |
| IE920229A1 (en) | Regulation of nucleic acid translation | |
| JP2024524526A5 (https=) | ||
| KR930701180A (ko) | 올리고 뉴클레오티드에 의한 세포 유착의 조절 | |
| Zhang et al. | The proline-rich acidic protein is epigenetically regulated and inhibits growth of cancer cell lines | |
| Hernández-Rivera et al. | NRAMP1 polymorphisms like susceptibility marker in Mexican focus of cutaneous leishmaniasis | |
| KR101783444B1 (ko) | miR-33-5p 를 이용한 뇌신경세포 보호 물질 스크리닝 방법 | |
| JP2022525545A5 (https=) | ||
| JP2024528284A5 (https=) | ||
| CA3237033A1 (en) | Methods of treating headaches and migraines with sodium voltage-gated channel alpha subunit 11 (scn11a) inhibitors | |
| JP2024524375A5 (https=) | ||
| JP2024529400A5 (https=) | ||
| KR20010072475A (ko) | 재발협착증을 치료하기 위한 ｄｎａ자임 및 치료 방법 | |
| JP2022525546A5 (https=) | ||
| JP2024535110A5 (https=) | ||
| Sprague et al. | The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissue | |
| RU2839162C2 (ru) | Молекула олигомерной нуклеиновой кислоты и ее применение |